AU Patent

AU2022221405A1 — Dosing regimen for missed doses for long-acting injectable paliperidone esters

Assigned to Janssen Pharmaceutica NV · Expires 2022-09-15 · 4y expired

What this patent protects

of the Invention The present application provides a method for treating patients in need of ) psychiatric treatment, wherein said patient is being treated with the 3-month formulation of paliperidone palmitate and fails to take the next scheduled dose of the 3-month formulatio…

USPTO Abstract

of the Invention The present application provides a method for treating patients in need of ) psychiatric treatment, wherein said patient is being treated with the 3-month formulation of paliperidone palmitate and fails to take the next scheduled dose of the 3-month formulation of 5 paliperidone palmitate

Drugs covered by this patent

Patent Metadata

Patent number
AU2022221405A1
Jurisdiction
AU
Classification
—
Expires
2022-09-15
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.